INHIBITION OF 12-O-TETRADECANOYLPHORBOL-13-ACETATE-INDUCED EPIDERMAL ORNITHINE DECARBOXYLASE ACTIVITY AND TUMOR PROMOTION BY N-(6-AMINOHEXYL)-5-CHLORO-1-NAPHTHALENESULFONAMIDE (W-7) IN MOUSE SKIN

被引:7
作者
NAKADATE, T [1 ]
YAMAMOTO, S [1 ]
AIZU, E [1 ]
KATO, R [1 ]
机构
[1] KEIO UNIV,SCH MED,DEPT PHARMACOL,35 SHINANOMACHI,SHINJUKU KU,TOKYO 169,JAPAN
关键词
D O I
10.1159/000138166
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:167 / 175
页数:9
相关论文
共 26 条
[11]  
KIKKAWA U, 1983, J BIOL CHEM, V258, P1442
[12]   INHIBITION OF 12-O-TETRADECANOYLPHORBOL-13-ACETATE-INDUCED EPIDERMAL ORNITHINE DECARBOXYLASE ACTIVITY BY LIPOXYGENASE INHIBITORS - POSSIBLE ROLE OF PRODUCT(S) OF LIPOXYGENASE PATHWAY [J].
NAKADATE, T ;
YAMAMOTO, S ;
ISHII, M ;
KATO, R .
CARCINOGENESIS, 1982, 3 (12) :1411-1414
[13]  
NAKADATE T, 1982, CANCER RES, V42, P2841
[14]  
NAKADATE T, 1984, GANN, V75, P214
[15]   INHIBITION OF TELEOCIDIN-CAUSED EPIDERMAL ORNITHINE DECARBOXYLASE INDUCTION BY PHOSPHOLIPASE-A2-INHIBITOR, CYCLOOXYGENASE-INHIBITOR AND LIPOXYGENASE-INHIBITOR [J].
NAKADATE, T ;
AIZU, E ;
YAMAMOTO, S ;
FUJIKI, H ;
SUGIMURA, T ;
KATO, R .
JAPANESE JOURNAL OF PHARMACOLOGY, 1985, 37 (03) :253-258
[16]   PHORBOL DIESTER RECEPTOR CO-PURIFIES WITH PROTEIN KINASE-C [J].
NIEDEL, JE ;
KUHN, LJ ;
VANDENBARK, GR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (01) :36-40
[17]   POTENT ANTITUMOR PROMOTING ACTIVITY OF N-(6-AMINOHEXYL)-5-CHLORO-1-NAPHTHALENESULFONAMIDE, A CALMODULIN ANTAGONIST, IN MOUSE SKIN TUMOR-FORMATION INDUCED BY 7,12-DIMETHYLBENZ[A]ANTHRACENE PLUS TELEOCIDIN [J].
NISHINO, H ;
IWASHIMA, A ;
NAKADATE, T ;
KATO, R ;
FUJIKI, H ;
SUGIMURA, T .
CARCINOGENESIS, 1984, 5 (02) :283-285
[18]   REDUCTION BY N-(6-AMINOHEXYL)-5-CHLORO-1-NAPHTHALENESULFONAMIDE (W-7), A CALMODULIN ANTAGONIST, IN THE NUMBER OF PHORBOL ESTER RECEPTORS IN MOUSE SKIN [J].
NISHINO, H ;
FUJIKI, H ;
SUGANUMA, M ;
HORIUCHI, T ;
IWASHIMA, A ;
SUGIMURA, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 124 (03) :726-730
[19]  
OBRIEN TG, 1975, CANCER RES, V35, P1662
[20]  
TANAKA T, 1982, MOL PHARMACOL, V22, P403